Abstract
Cancer Nano-Immunoengineering: The Marriage of Immunoengineering and Nanotechnology for Cancer Therapy
Highlights
Cancer immunotherapy, a strategy that harnesses the human immune system to fight against cancer is paving the path to curing it
Cancer immunotherapy can lead to durable outcomes, the percentage of patients who respond to this disruptive approach remains modest to date
A central question in cancer immunology is whether recognition of tumor antigens by the immune system leads to activation or tolerance
Summary
His research interests include the fundamental issue of cancer epigenetics, molecular targeted therapy and immunotherapy in brain tumor. Daxiang Cui is Professor at the Institute of Nano Biomedicine and Engineering, Shanghai JiaoTong University, and Editorin-chief of Nano Biomediicne and Engineering. Cancer immunotherapy, a strategy that harnesses the human immune system to fight against cancer is paving the path to curing it.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.